GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Melodiol Global Health Ltd (OTCPK:COPHD) » Definitions » 3-Year FCF Growth Rate

Melodiol Global Health (Melodiol Global Health) 3-Year FCF Growth Rate : 51.80% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Melodiol Global Health 3-Year FCF Growth Rate?

Melodiol Global Health's Free Cash Flow per Share for the six months ended in Dec. 2023 was $-0.29.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 51.80% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 51.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 8 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Melodiol Global Health was 51.80% per year. The lowest was -5.10% per year. And the median was 46.90% per year.


Competitive Comparison of Melodiol Global Health's 3-Year FCF Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Melodiol Global Health's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Melodiol Global Health's 3-Year FCF Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Melodiol Global Health's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Melodiol Global Health's 3-Year FCF Growth Rate falls into.



Melodiol Global Health 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Melodiol Global Health  (OTCPK:COPHD) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Melodiol Global Health 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Melodiol Global Health's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Melodiol Global Health (Melodiol Global Health) Business Description

Traded in Other Exchanges
Address
145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009
Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.

Melodiol Global Health (Melodiol Global Health) Headlines

From GuruFocus

Sierra Sage Herbs Acquired By Creso Pharma

By PRNewswire PRNewswire 02-07-2022